US2022110904A1PendingUtilityA1

Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular disease

68
Assignee: ESPERION THERAPEUTICS INCPriority: Mar 16, 2015Filed: Sep 2, 2021Published: Apr 14, 2022
Est. expiryMar 16, 2035(~8.7 yrs left)· nominal 20-yr term from priority
Inventors:Roger Schofield NewtonNoah Laban RosenbergDiane Elaine Macdougall
A61K 45/06A61P 9/00A61K 31/194A61K 31/225A61K 31/35A61K 31/366A61K 31/47A61K 31/405A61K 31/22A61K 31/505A61P 3/06A61P 9/10A61K 31/40A61K 2300/00A61P 43/00A61K 31/20
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are compositions comprising fixed doses of ETC-1002 and one or more statins. Also disclosed herein are methods for using fixed doses of ETC-1002 and one or more statins. Uses include methods of treating cardiovascular disease or reducing the risk of cardiovascular disease in a subject. Uses also include methods of treating hypercholesterolemia in a subject.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A fixed-dose combination of ETC-1002 and one or more statins selected from the group consisting of rosuvastatin, simvastatin, pravastatin, lovastatin, fluvastatin, pitavastatin, and atorvastatin, wherein
 the fixed dose of ETC-1002 is 120 mg or 180 mg,   the fixed dose of rosuvastatin is 20-40 mg,   the fixed dose of simvastatin is 40-80 mg,   the fixed dose of pravastatin is 80 mg,   the fixed dose of lovastatin is 20-40 mg,   the fixed dose of fluvastatin is 20-80 mg,   the fixed dose of pitavastatin is 1-4 mg, and   the fixed dose of atorvastatin is 40-80 mg.   
     
     
         2 . The fixed-dose combination of  claim 1 , wherein the fixed dose of ETC-1002 is 120 mg. 
     
     
         3 . The fixed-dose combination of  claim 1 , wherein the fixed dose of ETC-1002 is 180 mg. 
     
     
         4 . The fixed-dose combination of  claim 2 , wherein the fixed dose of rosuvastatin is 20-40 mg. 
     
     
         5 . The fixed-dose combination of  claim 3 , wherein the fixed dose of rosuvastatin is 20-40 mg. 
     
     
         6 . The fixed-dose combination of  claim 2 , wherein the fixed dose of simvastatin is 40-80 mg. 
     
     
         7 . The fixed-dose combination of  claim 3 , wherein the fixed dose of simvastatin is 40-80 mg. 
     
     
         8 . The fixed-dose combination of  claim 2 , wherein the fixed dose of pravastatin is 80 mg. 
     
     
         9 . The fixed-dose combination of  claim 3 , wherein the fixed dose of pravastatin is 80 mg. 
     
     
         10 . The fixed-dose combination of  claim 2 , wherein the fixed dose of lovastatin is 20-40 mg. 
     
     
         11 . The fixed-dose combination of  claim 3 , wherein the fixed dose of lovastatin is 20-40 mg. 
     
     
         12 . The fixed-dose combination of  claim 2 , wherein the fixed dose of fluvastatin is 20-80 mg. 
     
     
         13 . The fixed-dose combination of  claim 3 , wherein the fixed dose of fluvastatin is 20-80 mg. 
     
     
         14 . The fixed-dose combination of  claim 2 , wherein the fixed dose of pitavastatin is 1-4 mg. 
     
     
         15 . The fixed-dose combination of  claim 3 , wherein the fixed dose of pitavastatin is 1-4 mg. 
     
     
         16 . The fixed-dose combination of  claim 2 , wherein the fixed dose of atorvastatin is 40-80 mg. 
     
     
         17 . The fixed-dose combination of  claim 3 , wherein the fixed dose of atorvastatin is 40-80 mg.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.